Raymond James Financial
ETNB

Raymond James Financial’s 89bio ETNB Stock Holding History

Raymond James Financial’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-417,756
Closed -$6.14M – 5216
2025
Q3 		$6.14M Sell
417,756
-153,846
-27% -$1.57M ﹤0.01% 2326
2025
Q2 		$5.61M Buy
571,602
+189,311
+50% +$1.57M ﹤0.01% 2293
2025
Q1 		$2.78M Buy
382,291
+4,921
+1% +$43K ﹤0.01% 2757
2024
Q4 		$2.95M Buy
+377,370
New +$3.11M ﹤0.01% 2685

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Raymond James Financial's ETNB Position: Q4 2025 in Review

Raymond James Financial sold out of 89bio (ETNB) in Q4 2025, closing a stake of 417,756 shares — an estimated $6.14M sold.

Raymond James Financial first reported a position in ETNB in Q4 2024 and held it in 4 quarters. The position peaked at $6.14M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Raymond James Financial reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Raymond James Financial sold 417,756 89bio shares in Q4 2025, an estimated $6.14M.
  • Raymond James Financial first reported a position in 89bio in Q4 2024 and held it in 4 quarters.
  • Raymond James Financial's 89bio position peaked at $6.14M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Raymond James Financial's 13F filing for Q4 2025, filed 18 Feb 2026.